A clinical trial involving 420 people suggests that a vaccine for respiratory syncytial virus – a major cause of common colds – is safe and effective
Source:
https://www.newscientist.com/article/2251437-vaccine-for-major-common-cold-virus-could-be-ready-for-use-by-2024/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home